Thomas Maximilian Klueter
Department of Accounting and Control
University of Navarra
Spain
Biography
Thomas holds a PhD in Managerial Science and Applied Economics from University of Pennsylvania, an MA from University of Pennsylvania and University College Dublin and a BA Science from Duale Hochschule Baden-Wuertemberg. Prior to pursuing an academic career, he was a financial analyst and project manager at IBM and JP Morgan. In those functions, he was involved in several worldwide projects in corporate finance and business development. Thomas' research interests lie at the intersection of strategic entrepreneurship and innovation. He focuses on how established and emerging firms manage technological change and the strategies firms pursue to develop and commercialize new technologies. His work has been been published in Academy of Management Journal (forthcoming), the European Management Review, and Academy of Management Best Paper Proceedings (2013,2014), and has been presented at several international conferences.
Research Interest
1.Strategic Entrepreneurship 2.Technology Innovation 3.Inter-organizational partnerships
Publications
-
Pawar VG, Sos ML, Rode HB, Rabiller M, Heynck S, Van Otterlo WA, Thomas RK, Rauh D. Synthesis and biological evaluation of 4-anilinoquinolines as potent inhibitors of epidermal growth factor receptor. Journal of medicinal chemistry. 2010 Mar 11;53(7):2892-901.
-
Messmer EP, Sauerwein W, Heinrich T, Höpping W, Klueter-Reckmann D, Bornfeld N, Sack H, Förster M, Havers W. New and recurrent tumor foci following local treatment as well as external beam radiation in eyes of patients with hereditary retinoblastoma. Graefe's Archive for Clinical and Experimental Ophthalmology. 1990 Sep 1;228(5):426-31.
-
Erdmann J, Großhennig A, Braund PS, König IR, Hengstenberg C, Hall AS, Linsel-Nitschke P, Kathiresan S, Wright B, Trégouët DA, Cambien F. New susceptibility locus for coronary artery disease on chromosome 3q22. 3. Nature genetics. 2009 Mar 1;41(3):280-2.
